Lorenz Von Seidlein

Lorenz Von Seidlein was born in Germany and attended medical school in Dublin, Ireland. He completed a pediatric residency in Miami, an Infectious Disease Fellowship at UCLA and a PhD in epidemiology from the London School of Tropical Medicine and Hygiene. Between 1995 and 2000 he worked in The Gambia on the first evaluations of ACTs in subSaharan Africa. From 2000 through 2010 he was employed by the International Vaccine Institute in Seoul, Korea where he managed large vaccine evaluation projects including an oral cholera vaccine in Mozambique and Zanzibar. From 2006 he coordinated a trial of the malaria vaccine candidate RTS,S/ASO1 in Tanzania. From 2003 he collaborated with the Mahidol-Oxford Tropical Medicine Research Unit, Bangkok, Thailand on a large multicentre trial (AQUAMAT) to compare the efficacy of parenteral artesunate with parenteral quinine for severe malaria. From 2010 he coordinated the APMEN vivax working group in Darwin, Australia. From 2014 he worked on the evaluation of mass drug administrations to interrupt the transmission of malaria at the  Mahidol-Oxford Tropical Medicine Research Unit, Bangkok, Thailand. His current main interests are housing innovations to control and eliminate a range of diseases including malaria, respiratory tract infections and enteric diseases. Other interests include the the treatment of vivax malaria and the inclusion of vaccines in the targeted elimination of malaria.

https://www.tropicalmedicine.ox.ac.uk/team/lorenz-von-seidlein